1-8 of 8
Waleed Majeed, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mature, Adaptive-like CD56 DIM NK Cells in Chronic Myeloid Leukemia Patients in Treatment Free Remission

Mette Ilander, Heinrich Schlums, Ulla Olsson-Strömberg, Hanna Lähteenmäki, Tiina Kasanen, Perttu Koskenvesa, MD, Stina Söderlund, Martin Höglund, Ass Prof, Berit Markevärn, Anders Själander, Kourosh Lotfi, Claes Malm, Anna Lubking, MD, Marja Ekblom, Elena Holm, Mats Björeman, Sören Lehmann, Leif Stenke, MD PhD, Lotta Ohm, Waleed Majeed, MD, Martin C. Muller, Hans Ehrencrona, Henrik Hjorth-Hansen, MD PhD, Susanne Saussele, Francois-Xavier Mahon, MD PhD Professor, Kimmo Porkka, MD PhD, Joelle Guilhot, PhD, Yenan Bryceson, Johan Richter, MD PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 343.
https://doi.org/10.1182/blood.V126.23.343.343
Published: 2015
Journal Articles

Single-Cell Immune Signatures in Patients with Chronic Phase Chronic Myeloid Leukemia (CML) Treated with Nilotinib: An ENEST1st Sub Study

Stein-Erik Gullaksen, MSc, Jørn Skavland, PhD, Krzysztof Warzocha, MD PhD, Sonia Gavasso, PhD, Vinko Tosevski, PhD, Noortje Thielen, MDPhD, Jaroslava Voglova, MD, Augustin Ferrant, MD PhD, Werner Linkesch, MD, Josef Thaler, MD, Alois Lang, MD, Jesper Stentoft, Tobias Gedde-Dahl, MDPhD, Henrik Hjorth-Hansen, MD PhD, Waleed Majeed, MD, Gregor Verhoef, MD PhD, Andrzej Hellmann, MD PhD, Georgi G. Mihaylov, MD PhD, Claudia Dumrese, PhD, Frank Giles, MDMB, Andreas Hochhaus, MD, Sieghart Sopper, PhD, Leif Stenke, MD PhD, Boris Labar, MD PhD, Jeroen Janssen, MD, Kimmo Porkka, MD PhD, Gert J. Ossenkoppele, MD PhD, Satu Mustjoki, MD PhD, Dominik Wolf, MD, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4022.
https://doi.org/10.1182/blood.V126.23.4022.4022
Published: 2015
Journal Articles

Early Disease Relapse after Tyrosine Kinase Inhibitor Treatment Discontinuation in CML Is Related Both to Low Number and Impaired Function of NK-Cells

Mette Matilda Ilander, MSc, Ulla Olsson-Strömberg, MD PhD, Hanna Lähteenmäki, MSc, Kasanen Tiina, Perttu Koskenvesa, MD, Stina Söderlund, MD, Martin Höglund, MDPhD, Berit Markevärn, MD, Anders Själander, MD PhD, Kourosh Lotfi, MDPhD, Claes Malm, MD, Anna Lubking, MD, Marja Ekblom, MD PhD, Elena Holm, MD, Mats Björeman, MD, Sören Lehmann, MD PhD, Leif Stenke, MD PhD, Lotta Ohm, MD PhD, Waleed Majeed, MD, Markus Pfirrmann, PhD, Martin C Muller, MD, Joelle Guilhot, PhD, Hans Ehrencrona, MD PhD, Henrik Hjorth-Hansen, MD PhD, Susanne Saussele, Francois-Xavier Mahon, MD PhD, Kimmo Porkka, MD PhD, Johan Richter, MD PhD, Satu Mustjoki, MDPhD
Journal: Blood
Blood (2014) 124 (21): 812.
https://doi.org/10.1182/blood.V124.21.812.812
Published: 2014
Journal Articles

Dasatinib Treatment Induces Fast and Deep Responses In Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients In Chronic Phase: Clinical Results From a Randomized Phase 2 Study (NordCML006)

Henrik Hjorth-Hansen, MD, PhD, Johan Richter, MD, PhD, Leif Stenke, MD, PhD, Hans Ehrencrona, MD, PhD, Bjørn Tore Gjertsen, MD, PhD, Tobias Gedde-Dahl, III, MD, PhD, Perttu Koskenvesa, MD, Claes Malm, MD, Waleed Majeed, MD, Lotta Ohm, MD PhD, Martin Hoglund, MD PhD, Ulla Olsson-Strömberg, MD, PhD, Stina Söderlund, MD, Merja Suominen, MD, Kari Remes, MD PhD, Berit Markevärn, MD, Bengt Simonsson, MD PhD, Kimmo Porkka, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4032.
https://doi.org/10.1182/blood.V122.21.4032.4032
Published: 2013
Journal Articles

Early PK-Analysis Predicts Molecular Response In Patients With Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Treated With Frontline Nilotinib

Dominik Wolf, MD, Jorn Skavland, PhD, Christoph Seger, PhD, Sieghart Sopper, PhD, Wiktor-Wieslaw Jedrzejczak, MD, PhD, Dubravka Sertic, MD, Jaroslava Voglova, MD, Satu Mustjoki, MD PhD, Leif Stenke, MD, PhD, Augustin Ferrant, MD, PhD, Richard Greil, MD, Alois Lang, MD, Josef Thaler, MD, PhD, Werner Linkesch, MD, Antica Duletić-Načinović, MD , PhD, Andrzej Hellmann, MD, PhD, Georgi G. Mihaylov, MD, PhD, Tobias Gedde-Dahl, III, MD, PhD, Henrik Hjorth-Hansen, MD, PhD, Waleed Majeed, MD, Jesper Stentoft, MD, Gregor Verhoef, M.D. Ph.D., Jan Van Droogenbroeck, MD, Ute Mark, Jens Haenig, Nidas Jurjonas, Frank Giles, MD MB, Andreas Hochhaus, MD, Kimmo Porkka, MD, PhD, Gert J. Ossenkoppele, MD PhD, Bjorn T. Gjertsen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1485.
https://doi.org/10.1182/blood.V122.21.1485.1485
Published: 2013
Journal Articles

Immune Monitoring In Patients With Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Treated With Frontline Nilotinib

Sieghart Sopper, PhD, Satu Mustjoki, MD, PhD, Angelica Loskog, PhD, Bjorn T Gjertsen, MD PhD, Richard Greil, MD, Alois Lang, MD, Werner Linkesch, MD, Josef Thaler, MD, Tobias Gedde-Dahl, III, MD, PhD, Henrik Hjorth-Jansen, MD, Waleed Majeed, MD, Kourosh Lofti, MD, PhD, Johan Richter, MD, PhD, Sören Lehman, MD, Leif Stenke, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Jesper Stentoft, MD, Ward Posthuma, MD, PhD, Willem Smit, Edo Vellenga, MD, PhD, Gregor Verhoef, Augustin Ferrant, MD, PhD, Jan Van Droogenbroeck, MD, Ute Mark, Jens Haenig, Nidas Jurjonas, Gunther Gastl, Prof., Dr., Frank Giles, MD MB, Andreas Hochhaus, MD, Gert J. Ossenkoppele, MD PhD, Kimmo Porkka, MD, PhD, Dominik Wolf, MD
Journal: Blood
Blood (2013) 122 (21): 2731.
https://doi.org/10.1182/blood.V122.21.2731.2731
Published: 2013
Journal Articles

Favorable Therapeutic Responses in Newly Diagnosed CML-CP Patients Induced by Dasatinib Are Reflected At the CD34+CD38+ Progenitor Cell but Not At the CD34+CD38− Stem Cell Level: Results From Randomized NordCML006 Study

Satu Mustjoki, MD, PhD, Johan Richter, MD, PhD, Gisela Barbany, MD, PhD, Hans Ehrencrona, MD, PhD, Ingunn Dybedal, MD, PhD, Thoas Fioretos, MD, PhD, Tobias Gedde-Dahl, MD, PhD, Bjorn Gjertsen, MD, PhD, Randi Hovland, PhD, Sari E Jalkanen, MSc, Dag Josefsen, MD, PhD, Perttu Koskenvesa, MD, Carin Lassen, Msc, Kirsi Latvala, Waleed Majeed, MD, Claes Malm, MD, Berit Markevärn, MD, Ali Mosfegh, PhD, Lotta Ohm, MD, Tor Olofsson, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Katrin Rapakko, PhD, Kari Remes, MD PhD, Jesper Stentoft, MD, PhD, Leif Stenke, MD, PhD, Merja Suominen, MD, Sara Thunberg, PhD, Ole Weiss Bjerrum, MD, PhD, Bengt Simonsson, MD, PhD, Kimmo Porkka, MD, PhD, Henrik Hjorth-Hansen, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 784.
https://doi.org/10.1182/blood.V118.21.784.784
Published: 2011
Journal Articles

The Proportion of Ph+ CD34 + CD38 neg Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI-Therapy. Data From a Randomized Phase II NordCML006 Study

Satu Mustjoki, MD, PhD, Johan Richter, MD, PhD, Gisela Barbany, MD, PhD, Ingunn Dybedal, MD, PhD, Thoas Fioretos, MD, PhD, Tobias Gedde-Dahl, MD, PhD, Bjorn T. Gjertsen, MD, PhD, Randi Hovland, PhD, Sari Jalkanen, Msc, Dag Josefsen, MD, PhD, Perttu Koskenvesa, MD, Carin Lassen, Kirsi Latvala, Waleed Majeed, MD, Claes Malm, MD, Berit Markevärn, MD, Ali Moshfegh, PhD, Lotta Ohm, MD, Tor Olofsson, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Katrin Rapakko, PhD, Kari Remes, MD, PhD, Jesper Stentoft, MD, PhD, Leif Stenke, MD, PhD, Merja Suominen, MD, Sara Thunberg, MD, PhD, Ole Weiss Bjerrum, MD, PhD, Bengt Simonsson, MD, PhD, Kimmo Porkka, MD, PhD, Henrik Hjorth-Hansen, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 667.
https://doi.org/10.1182/blood.V116.21.667.667
Published: 2010